Merit Financial Group’s Revolution Medicines RVMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1M Buy
4,874
+1,087
+29% +$215K 0.01% 1148
2026
Q2
$709K Buy
+3,787
New +$553K ﹤0.01% 1283

Other funds holding RVMD

Merit Financial Group's RVMD Position: Q3 2026 in Review

Merit Financial Group increased its Revolution Medicines (RVMD) stake by 29% in Q3 2026, buying an estimated $215K and bringing the position to 4,874 shares worth $1M. The position accounts for 0.01% of the portfolio, ranked #1148.

Merit Financial Group first reported a position in RVMD in Q2 2026 and has held it in 2 quarters since. 756 funds tracked by Wall St. Rank hold RVMD as of Q3 2026.

  • Merit Financial Group held 4,874 shares of Revolution Medicines worth $1M as of Q3 2026.
  • Merit Financial Group bought 1,087 Revolution Medicines shares in Q3 2026, an estimated $215K.
  • Revolution Medicines made up 0.01% of Merit Financial Group's portfolio in Q3 2026, its #1148 holding.
  • Merit Financial Group first reported a position in Revolution Medicines in Q2 2026 and has held it in 2 quarters since.
  • 756 funds tracked by Wall St. Rank held Revolution Medicines as of Q3 2026.

Based on Merit Financial Group's 13F filing for Q3 2026, filed 6 Nov 2026.